Zhijie Xu

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 29

Top Topics

Transforming Growth Factor

Papillary Thyroid

Immune Response

Top Venues

Signal transduction and targeted therapy

Journal of natural products

International journal of general medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xi Chen, Yuanliang Yan, Yuanhong Liu, Qiaoli Yi, Zhijie Xu
Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial-Mesenchymal Transition in an Ovarian Tumor. Journal of natural products (2024)
Yuanliang Yan, Shangjun Zhou, Xi Chen, Qiaoli Yi, Songshan Feng, Zijin Zhao, Yuanhong Liu, Qiuju Liang, Zhijie Xu, Zhi Li, Lun-Quan Sun
Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis. Signal transduction and targeted therapy 9 (1) (2024)
Yuanliang Yan, Shangjun Zhou, Xi Chen, Qiaoli Yi, Songshan Feng, Zijin Zhao, Yuanhong Liu, Qiuju Liang, Zhijie Xu, Zhi Li, Lun-Quan Sun
Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis. Signal transduction and targeted therapy 9 (1) (2024)
Xi Chen, Yuanliang Yan, Yuanhong Liu, Qiaoli Yi, Zhijie Xu
Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial-Mesenchymal Transition in an Ovarian Tumor. Journal of natural products 87 (4) (2024)
Xi Chen, Yuanliang Yan, Yuanhong Liu, Qiaoli Yi, Zhijie Xu
Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial-Mesenchymal Transition in an Ovarian Tumor. Journal of natural products 87 (4) (2024)
Zedong Jiang, Qianlong Kang, Hong Qian, Zhijie Xu, Huan Tong, Jiaqing Yang, Li Li, Renwei Li, Guangqi Li, Fei Chen, Nan Lin, Yunuo Zhao, Hua-Shan Shi, Juan Huang, Xue-Lei Ma
Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression. Signal transduction and targeted therapy 9 (1) (2024)
Zedong Jiang, Qianlong Kang, Hong Qian, Zhijie Xu, Huan Tong, Jiaqing Yang, Li Li, Renwei Li, Guangqi Li, Fei Chen, Nan Lin, Yunuo Zhao, Hua-Shan Shi, Juan Huang, Xue-Lei Ma
Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression. Signal transduction and targeted therapy 9 (1) (2024)
Xi Chen, Yuanliang Yan, Yuanhong Liu, Qiaoli Yi, Zhijie Xu
Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial-Mesenchymal Transition in an Ovarian Tumor. Journal of natural products 87 (4) (2024)
Zedong Jiang, Qianlong Kang, Hong Qian, Zhijie Xu, Huan Tong, Jiaqing Yang, Li Li, Renwei Li, Guangqi Li, Fei Chen, Nan Lin, Yunuo Zhao, Hua-Shan Shi, Juan Huang, Xue-Lei Ma
Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression. Signal transduction and targeted therapy 9 (1) (2024)
Yuanliang Yan, Shangjun Zhou, Xi Chen, Qiaoli Yi, Songshan Feng, Zijin Zhao, Yuanhong Liu, Qiuju Liang, Zhijie Xu, Zhi Li, Lun-Quan Sun
Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis. Signal transduction and targeted therapy 9 (1) (2024)
Xi Chen, Yuanliang Yan, Wang-Rui Liu, Yuanhong Liu, Abhimanyu Thakur, Qiuju Liang, Zhijie Xu
Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti-programmed death receptor ligand 1 therapy response of triple-negative breast cancer. Clinical and translational medicine 13 (7) (2023)
Zhiyao He, Lei Yu, Zhijie Xu, Chenyu Sun
Clinical, Translational and Experimental Pharmacotherapeutics Advances. Journal of clinical medicine 12 (3) (2023)
Zhiyao He, Lei Yu, Zhijie Xu, Chenyu Sun
Clinical, Translational and Experimental Pharmacotherapeutics Advances. Journal of clinical medicine 12 (3) (2023)
Kuan Hu, Juanni Li, Zhiming Wang, Yuanliang Yan, Yuan Cai, Bi Peng, Jinzhou Huang, Dongren He, Lei Zhou, Zhijie Xu, Yiming Tao
BTB/POZ domain-containing protein 7/hypoxia-inducible factor 1 alpha signalling axis modulates hepatocellular carcinoma metastasis. Clinical and translational medicine 11 (10) (2022)
Xiangyuan Qiu, Xinying Li, Yuanliang Yan, Yuan Cai, Qiuju Liang, Bi Peng, Zhijie Xu, Muzhang Xiao, Fada Xia, Jinwu Peng
Identification of m6A-Associated Gene DST as a Prognostic and Immune-Associated Biomarker in Breast Cancer Patients. International journal of general medicine 15 (2022)
Xiang Wang, Zhijie Xu, Xinxin Ren, Xi Chen, Qiaoli Yi, Shuangshuang Zeng, Abhimanyu Thakur, Zhicheng Gong, Yuanliang Yan
MTHFR inhibits TRC8-mediated HMOX1 ubiquitination and regulates ferroptosis in ovarian cancer. Clinical and translational medicine 12 (9) (2022)
Zeyu Zhang, Xiangyuan Qiu, Yuanliang Yan, Qiujiu Liang, Yuan Cai, Bi Peng, Zhijie Xu, Fada Xia
Evaluation of Ferroptosis-related Gene AKR1C1 as a Novel Biomarker Associated with the Immune Microenvironment and Prognosis in Breast Cancer. International journal of general medicine 14 (2021)
Xinxin Ren, Xiang Wang, Bi Peng, Qiuju Liang, Yuan Cai, Kewa Gao, Yongbin Hu, Zhijie Xu, Yuanliang Yan
Significance of TEAD Family in Diagnosis, Prognosis and Immune Response for Ovarian Serous Carcinoma. International journal of general medicine 14 (2021)
Jing Wang, Minxiang Lei, Zhijie Xu
Aberrant expression of PROS1 correlates with human papillary thyroid cancer progression. PeerJ 9 (2021)
Yuanliang Yan, Guijie Guo, Jinzhou Huang, Ming Gao, Qian Zhu, Shuangshuang Zeng, Zhicheng Gong, Zhijie Xu
Current understanding of extrachromosomal circular DNA in cancer pathogenesis and therapeutic resistance. Journal of hematology & oncology 13 (1) (2020)
Yuanliang Yan, Shuangshuang Zeng, Zhicheng Gong, Zhijie Xu
Clinical implication of cellular vaccine in glioma: current advances and future prospects. Journal of experimental & clinical cancer research : CR 39 (1) (2020)
Zhijie Xu, Xiang Wang, Xi Chen, Shuangshuang Zeng, Zhicheng Gong, Yuanliang Yan
Pembrolizumab as the first-line monotherapy for non-small-cell lung cancer with a low programmed death ligand 1 threshold. Journal of cell communication and signaling 14 (1) (2020)
Yuanliang Yan, Shuangshuang Zeng, Xiang Wang, Zhicheng Gong, Zhijie Xu
A Machine Learning Algorithm for Predicting Therapeutic Response to Anti-PD1. Technology in cancer research & treatment 18 (2019)
Yuanliang Yan, Zhicheng Gong, Zhijie Xu
Vitamin D supplementation and colorectal cancer prognosis. Medical oncology (Northwood, London, England) 36 (8) (2019)
Xiang Wang, Zhijie Xu, Xi Chen, Xinxin Ren, Jie Wei, Shuyi Zhou, Xue Yang, Shuangshuang Zeng, Long Qian, Geting Wu, Zhicheng Gong, Yuanliang Yan
A tropomyosin receptor kinase family protein, NTRK2 is a potential predictive biomarker for lung adenocarcinoma. PeerJ 7 (2019)
Yuanliang Yan, Zhi Li, Shuangshuang Zeng, Xiang Wang, Zhicheng Gong, Zhijie Xu
FGFR2-mediated phosphorylation of PTEN at tyrosine 240 contributes to the radioresistance of glioma. Journal of cell communication and signaling 13 (3) (2019)
Zhijie Xu, Xiang Wang, Xi Chen, Shuangshuang Zeng, Long Qian, Jie Wei, Zhicheng Gong, Yuanliang Yan
Identification of Aloperine as an anti-apoptotic Bcl2 protein inhibitor in glioma cells. PeerJ 7 (2019)
Yuanliang Yan, Zhijie Xu, Long Qian, Shuangshuang Zeng, Yangying Zhou, Xi Chen, Jie Wei, Zhicheng Gong
Identification of CAV1 and DCN as potential predictive biomarkers for lung adenocarcinoma. American journal of physiology. Lung cellular and molecular physiology 316 (4) (2019)
Yuanliang Yan, Weiping Su, Shuangshuang Zeng, Long Qian, Xi Chen, Jie Wei, Na Chen, Zhicheng Gong, Zhijie Xu
Effect and Mechanism of Tanshinone I on the Radiosensitivity of Lung Cancer Cells. Molecular pharmaceutics 15 (11) (2018)